Electrothermal bipolar coagulation for pelvic exenterations

Brian Slomovitz, Pedro T. Ramirez, Michael Frumovitz, Pamela T. Soliman, Michael Bevers, Robert L. Coleman, Charles Levenback

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Objectives.: The morbidity associated with pelvic exenteration is high; however, patients undergoing this procedure have no other curative treatment options. Excessive blood loss is a common complication of this procedure. We evaluated whether use of an electrothermal bipolar coagulator (LigaSure Atlas, ValleyLab, Boulder, Colorado, USA) during pelvic exenteration is safe and whether it reduces intraoperative blood loss, intraoperative blood transfusion requirements, and length of hospital stay. Methods.: Between September 2003 and January 2005, 12 patients underwent pelvic exenteration (total, anterior, or posterior) performed using the electrothermal bipolar coagulator. Estimated blood loss, transfusion requirements, length of hospital stay, and complications necessitating reoperation were evaluated. Results.: The mean age was 55 years (range, 30-77), the mean estimated blood loss was 1931 ml (range, 1300-1500 ml), the mean number of units of packed red blood cells transfused intraoperatively was 3.4 U (range, 2-12 U), the mean operative time was 609 min (range, 400-940 min), and the mean length of hospital stay was 19.9 days (range, 7-27). There were no intraoperative complications related to the electrothermal bipolar coagulator use. None of the patients had any complications necessitating reoperation. Conclusions.: Use of the electrothermal bipolar coagulator device during pelvic exenteration is safe and may decrease blood loss and the number of units of blood that must be transfused intraoperatively.

Original languageEnglish (US)
Pages (from-to)534-536
Number of pages3
JournalGynecologic Oncology
Volume102
Issue number3
DOIs
StatePublished - Sep 2006
Externally publishedYes

Fingerprint

Pelvic Exenteration
Length of Stay
Reoperation
Blood Transfusion
Atlases
Intraoperative Complications
Operative Time
Erythrocytes
Morbidity
Equipment and Supplies

Keywords

  • Pelvic exenteration
  • Surgical technique

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Oncology

Cite this

Slomovitz, B., Ramirez, P. T., Frumovitz, M., Soliman, P. T., Bevers, M., Coleman, R. L., & Levenback, C. (2006). Electrothermal bipolar coagulation for pelvic exenterations. Gynecologic Oncology, 102(3), 534-536. https://doi.org/10.1016/j.ygyno.2006.01.013

Electrothermal bipolar coagulation for pelvic exenterations. / Slomovitz, Brian; Ramirez, Pedro T.; Frumovitz, Michael; Soliman, Pamela T.; Bevers, Michael; Coleman, Robert L.; Levenback, Charles.

In: Gynecologic Oncology, Vol. 102, No. 3, 09.2006, p. 534-536.

Research output: Contribution to journalArticle

Slomovitz, B, Ramirez, PT, Frumovitz, M, Soliman, PT, Bevers, M, Coleman, RL & Levenback, C 2006, 'Electrothermal bipolar coagulation for pelvic exenterations', Gynecologic Oncology, vol. 102, no. 3, pp. 534-536. https://doi.org/10.1016/j.ygyno.2006.01.013
Slomovitz B, Ramirez PT, Frumovitz M, Soliman PT, Bevers M, Coleman RL et al. Electrothermal bipolar coagulation for pelvic exenterations. Gynecologic Oncology. 2006 Sep;102(3):534-536. https://doi.org/10.1016/j.ygyno.2006.01.013
Slomovitz, Brian ; Ramirez, Pedro T. ; Frumovitz, Michael ; Soliman, Pamela T. ; Bevers, Michael ; Coleman, Robert L. ; Levenback, Charles. / Electrothermal bipolar coagulation for pelvic exenterations. In: Gynecologic Oncology. 2006 ; Vol. 102, No. 3. pp. 534-536.
@article{b84637bd4fae415498a10d2ae3e72eeb,
title = "Electrothermal bipolar coagulation for pelvic exenterations",
abstract = "Objectives.: The morbidity associated with pelvic exenteration is high; however, patients undergoing this procedure have no other curative treatment options. Excessive blood loss is a common complication of this procedure. We evaluated whether use of an electrothermal bipolar coagulator (LigaSure Atlas, ValleyLab, Boulder, Colorado, USA) during pelvic exenteration is safe and whether it reduces intraoperative blood loss, intraoperative blood transfusion requirements, and length of hospital stay. Methods.: Between September 2003 and January 2005, 12 patients underwent pelvic exenteration (total, anterior, or posterior) performed using the electrothermal bipolar coagulator. Estimated blood loss, transfusion requirements, length of hospital stay, and complications necessitating reoperation were evaluated. Results.: The mean age was 55 years (range, 30-77), the mean estimated blood loss was 1931 ml (range, 1300-1500 ml), the mean number of units of packed red blood cells transfused intraoperatively was 3.4 U (range, 2-12 U), the mean operative time was 609 min (range, 400-940 min), and the mean length of hospital stay was 19.9 days (range, 7-27). There were no intraoperative complications related to the electrothermal bipolar coagulator use. None of the patients had any complications necessitating reoperation. Conclusions.: Use of the electrothermal bipolar coagulator device during pelvic exenteration is safe and may decrease blood loss and the number of units of blood that must be transfused intraoperatively.",
keywords = "Pelvic exenteration, Surgical technique",
author = "Brian Slomovitz and Ramirez, {Pedro T.} and Michael Frumovitz and Soliman, {Pamela T.} and Michael Bevers and Coleman, {Robert L.} and Charles Levenback",
year = "2006",
month = "9",
doi = "10.1016/j.ygyno.2006.01.013",
language = "English (US)",
volume = "102",
pages = "534--536",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Electrothermal bipolar coagulation for pelvic exenterations

AU - Slomovitz, Brian

AU - Ramirez, Pedro T.

AU - Frumovitz, Michael

AU - Soliman, Pamela T.

AU - Bevers, Michael

AU - Coleman, Robert L.

AU - Levenback, Charles

PY - 2006/9

Y1 - 2006/9

N2 - Objectives.: The morbidity associated with pelvic exenteration is high; however, patients undergoing this procedure have no other curative treatment options. Excessive blood loss is a common complication of this procedure. We evaluated whether use of an electrothermal bipolar coagulator (LigaSure Atlas, ValleyLab, Boulder, Colorado, USA) during pelvic exenteration is safe and whether it reduces intraoperative blood loss, intraoperative blood transfusion requirements, and length of hospital stay. Methods.: Between September 2003 and January 2005, 12 patients underwent pelvic exenteration (total, anterior, or posterior) performed using the electrothermal bipolar coagulator. Estimated blood loss, transfusion requirements, length of hospital stay, and complications necessitating reoperation were evaluated. Results.: The mean age was 55 years (range, 30-77), the mean estimated blood loss was 1931 ml (range, 1300-1500 ml), the mean number of units of packed red blood cells transfused intraoperatively was 3.4 U (range, 2-12 U), the mean operative time was 609 min (range, 400-940 min), and the mean length of hospital stay was 19.9 days (range, 7-27). There were no intraoperative complications related to the electrothermal bipolar coagulator use. None of the patients had any complications necessitating reoperation. Conclusions.: Use of the electrothermal bipolar coagulator device during pelvic exenteration is safe and may decrease blood loss and the number of units of blood that must be transfused intraoperatively.

AB - Objectives.: The morbidity associated with pelvic exenteration is high; however, patients undergoing this procedure have no other curative treatment options. Excessive blood loss is a common complication of this procedure. We evaluated whether use of an electrothermal bipolar coagulator (LigaSure Atlas, ValleyLab, Boulder, Colorado, USA) during pelvic exenteration is safe and whether it reduces intraoperative blood loss, intraoperative blood transfusion requirements, and length of hospital stay. Methods.: Between September 2003 and January 2005, 12 patients underwent pelvic exenteration (total, anterior, or posterior) performed using the electrothermal bipolar coagulator. Estimated blood loss, transfusion requirements, length of hospital stay, and complications necessitating reoperation were evaluated. Results.: The mean age was 55 years (range, 30-77), the mean estimated blood loss was 1931 ml (range, 1300-1500 ml), the mean number of units of packed red blood cells transfused intraoperatively was 3.4 U (range, 2-12 U), the mean operative time was 609 min (range, 400-940 min), and the mean length of hospital stay was 19.9 days (range, 7-27). There were no intraoperative complications related to the electrothermal bipolar coagulator use. None of the patients had any complications necessitating reoperation. Conclusions.: Use of the electrothermal bipolar coagulator device during pelvic exenteration is safe and may decrease blood loss and the number of units of blood that must be transfused intraoperatively.

KW - Pelvic exenteration

KW - Surgical technique

UR - http://www.scopus.com/inward/record.url?scp=33748462440&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748462440&partnerID=8YFLogxK

U2 - 10.1016/j.ygyno.2006.01.013

DO - 10.1016/j.ygyno.2006.01.013

M3 - Article

VL - 102

SP - 534

EP - 536

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 3

ER -